molsidomine has been researched along with Ventricular Fibrillation in 2 studies
Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of the novel antianginal agent molsidomine on the incidence of spontaneous ventricular fibrillation during myocardial ischemia and reperfusion was investigated in the anesthetized dog." | 7.66 | Effect of molsidomine on spontaneous ventricular fibrillation following myocardial ischemia and reperfusion in the dog. ( Kettenbach, B; Martorana, PA; Mogilev, AM; Nitz, RE, 1983) |
| "The cardioprotective and antithrombotic activity of molsidomine, a novel therapeutic agent for the treatment of coronary heart disease, was investigated in a series of animal models of myocardial ischemia." | 4.77 | The activity of molsidomine in experimental models of ischemic cardiac disease. ( Martorana, PA; Nitz, RE, 1985) |
| "The effect of the novel antianginal agent molsidomine on the incidence of spontaneous ventricular fibrillation during myocardial ischemia and reperfusion was investigated in the anesthetized dog." | 3.66 | Effect of molsidomine on spontaneous ventricular fibrillation following myocardial ischemia and reperfusion in the dog. ( Kettenbach, B; Martorana, PA; Mogilev, AM; Nitz, RE, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martorana, PA | 2 |
| Mogilev, AM | 1 |
| Kettenbach, B | 1 |
| Nitz, RE | 2 |
1 review available for molsidomine and Ventricular Fibrillation
| Article | Year |
|---|---|
The activity of molsidomine in experimental models of ischemic cardiac disease.
Topics: Animals; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dogs; Electric Stimulation; | 1985 |
1 other study available for molsidomine and Ventricular Fibrillation
| Article | Year |
|---|---|
Effect of molsidomine on spontaneous ventricular fibrillation following myocardial ischemia and reperfusion in the dog.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dogs; Female; Ligation; Male; Molsidomine; Oxadiaz | 1983 |